Impact of Decalcification on Receptor Status in Breast Cancer
Authors:
- Farbod DarvishianFDFarbod Darvishian
- Stephanie KrauterSKStephanie Krauter
- Luis ChiribogaLCLuis Chiriboga
- Maryann D. GangiMGMaryann D. Gangi
- Jonathan MelamedJMJonathan Melamed
- 17 October 2011
- journal article
- letter
- Published by Hindawi Limited in The Breast Journal
- Vol. 17 (6) , 689-691
Abstract
Click on the article title to read more.Keywords
This publication has 9 references indexed in Scilit:
- Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic ConsiderationsJournal of Clinical Oncology, 2009
- Case 30-2008New England Journal of Medicine, 2008
- Technical pitfalls potentially affecting diagnoses in immunohistochemistryJournal of Clinical Pathology, 2008
- Surgical Removal of the Primary Tumor Increases Overall Survival in Patients With Metastatic Breast Cancer: Analysis of the 1988–2003 SEER DataAnnals of Surgical Oncology, 2007
- Complete Excision of Primary Breast Tumor Improves Survival of Patients With Metastatic Breast Cancer at DiagnosisJournal of Clinical Oncology, 2006
- Bimodal Frequency Distribution of Estrogen Receptor Immunohistochemical Staining Results in Breast CancerAmerican Journal of Clinical Pathology, 2005
- Does aggressive local therapy improve survival in metastatic breast cancer?Surgery, 2002
- Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast CancerJournal of Clinical Oncology, 1999
- Effects of Decalcification on Immunoperoxidase StainingAmerican Journal of Surgical Pathology, 1986